ACS omega · 2025
Organically Functionalized Magnesium Phyllosilicates: Surface Engineering and Antibacterial Performance.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sakavitsi Viktoria, Fotiadou Renia, Subrati Mohammed, Datta Kasibhatta Kumara Ramanatha, Baroud Turki N, Behera Swarnamayee, Spyrou Konstantinos, Hammami Mohamed A, Zygouri Panagiota, Stamatis Haralambos, Yentekakis Ioannis V, Gournis Dimitrios P
Аннотация
Synthetic clay analogues (SCAs) of a new organosilicate layered material family, in contrast to common clays, are produced via an in situ room-temperature sol-gel route, providing the possibility for the design and synthesis of diverse, tailor-made functional groups on the surface and interior of the synthetic clay sheets. In this work, we introduce organophyllosilicates bearing different functional end groups, which are synthesized by a magnesium metal salt precursor and organosilanes such as (3-aminopropyl)-triethoxysilane (APTEOS), N-[3-(trimethoxysilyl)-propyl]-ethylenediamine (EDAPTEOS), N-(3-trimethoxysilylpropyl)-diethylenetriamine (TAPTMOS), 1,4-bis-(triethoxysilyl)-benzene (BTB), tetraethyl orthosilicate (TEOS), 3-glycidoxypropyltrimethoxysilane (GLYMO), and (3-chloropropyl)-trimethoxysilane (CPTMOS). The surface free energy for various organosynthetic clay analogues lies in the 29-252 mJ/m2 range. SCA's antimicrobial activity was tested against both Gram-negative and Gram-positive bacteria to evaluate the effect of surface functionalization on the viability of these microorganisms. The amino-SCAs displayed higher antibacterial activity compared to epoxy-SCAs, presenting a dose-dependent effect and a structure-dependent motif. Furthermore, Gram-positive bacteria were more susceptible to SCA treatment than Gram-negative.